A Randomized, 26-week, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Galantamine in the Treatment of Dementia Secondary to Cerebrovascular Disease
- O'Connor, Daniel (Primary Chief Investigator (PCI))
Project: Research
Project: Research